Abstract | PURPOSE: PATIENTS AND METHODS: HDGF expression in 317 patients with gastric carcinoma (233 males and 84 females) with ages ranging from 26 to 81 years (median, 60 years) was analyzed by immunohistochemistry. Samples with >90% of tumor cells to express positive immunoreactivity similar to or stronger than that in endothelial cells both for nucleus and cytoplasm were regarded as HDGF index level 2, and others as HDGF index level 1. RESULTS: One hundred and eighty-two cases showed level 1 HDGF expression, whereas 135 cases showed level 2 HDGF expression. Patients with level 2 expression showed higher rates of proximal tumor location (P < 0.0001), large tumor size (P < 0.0001), infiltrative tumor growth (P < 0.0001), presence of vascular and lymphatic invasion (P < 0.0001 for both), presence of lymph node metastasis (P < 0.0001), deep tumor invasion (P < 0.0001), and poorer disease-free and overall survival (P < 0.0001 for both) compared to those with level 1 expression. Multivariate analysis revealed HDGF expression level as an independent prognosticator for disease-free and overall survival. CONCLUSION: HDGF expression level was shown to be a prognostic factor for gastric carcinoma.
|
Authors | Shinji Yamamoto, Yasuhiko Tomita, Yoshihiko Hoshida, Shuji Takiguchi, Yoshiyuki Fujiwara, Takushi Yasuda, Yuichiro Doki, Kenya Yoshida, Katsuyuki Aozasa, Hideji Nakamura, Morito Monden |
Journal | Clinical cancer research : an official journal of the American Association for Cancer Research
(Clin Cancer Res)
Vol. 12
Issue 1
Pg. 117-22
(Jan 01 2006)
ISSN: 1078-0432 [Print] United States |
PMID | 16397032
(Publication Type: Journal Article)
|
Chemical References |
- Biomarkers, Tumor
- Intercellular Signaling Peptides and Proteins
- hepatoma-derived growth factor
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Biomarkers, Tumor
(analysis)
- Carcinoma
(metabolism, pathology)
- Female
- Humans
- Immunohistochemistry
- Intercellular Signaling Peptides and Proteins
(biosynthesis)
- Lymphatic Metastasis
(pathology)
- Male
- Middle Aged
- Prognosis
- Stomach Neoplasms
(metabolism, pathology)
|